AMANDA KEARNEY: Open Payments
NPI 1194271163 · WELDON SPRING, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,452 in 327 payments from 22 companies in 2025. Trend: 2023 $1,461 · 2024 $2,644 · 2025 $4,452
Food & beverage: $4,428Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $728 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $614 |
| Vanda Pharmaceuticals Inc. | 34 | $496 |
| Otsuka America Pharmaceutical, Inc. | 38 | $403 |
| Neurocrine BioSciences, Inc. | 21 | $370 |
| Corium, LLC | 27 | $256 |
| Axsome Therapeutics, Inc. | 21 | $246 |
| Teva Pharmaceuticals USA, Inc. | 14 | $236 |
| Alkermes, Inc. | 23 | $235 |
| Lundbeck LLC | 12 | $181 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, INGREZZA, Azstarys, Auvelity, ARISTADA.
Industry payments across MO — which companies pay providers there.
